The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.96.4.905

In the group of menopausal and post-menopausal depressions studied the beneficial effect of estrogenic hormone was confined to the relief of vasomotor symptoms with associated improvement in feelings of well-being. There was no evidence that the depressive illness as such was influenced specifically or its course shortened.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.